Clinical performance of the TCu 380A and TCu 220C IUDs in four developing country family planning clinics

Farr, Gaston; Amatya, Ramesh; Betancourt, JoséDelgado; David, M.; Alfonso, Lydia A.; Dacalos, Emilia

doi:10.1016/0010-7824(94)90059-0

Cited by 15 publications

(4 citation statements)

References 16 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Cultural background may be a factor influencing outcomes. Lower levels of pain have been observed in Chile 17 , Denmark 19 and developing countries 20,21 in comparison to the United Kingdom 22 and Sweden 23 .…”

Section: Differences In Results In Relation To Other Studiesmentioning

confidence: 97%

Patients’ experiences and providers’ observations on pain during intrauterine device insertion

Akintomide¹,

Brima

Sewell

et al. 2015

The European Journal of Contraception & Reproductive Health

View full text Add to dashboard Cite

ObjectiveTo determine women's (patients') experiences of intrauterine device (IUD) insertion under our current practice and the extent to which these agreed with the observations of the health professionals (providers) who had performed the IUD insertion procedures. MethodQuestionnaires were used to collect information on women's experiences of the IUD insertion procedure from both patients and providers in a sexual and reproductive health service. ResultsOverall response rates were high (77%, 284 responses in total). Seventy-three percent of patients were nulliparous and over half nulligravid. The providers predominantly used local anaesthesia for IUD insertions (93%). Most patients reported being anxious before their procedure (86%). Patients mainly described the overall experience of their IUD insertion procedure as being associated with 'minimal discomfort/nothing' (42%) or 'uncomfortable' (41%). 'Minimal discomfort/nothing' (56%) and 'uncomfortable' (33%) were the main observations of providers. When responses of patients and their providers were compared, agreement was slight for reported pain levels (k = 0.167 CI [0.13 -0.24]). Patients' reported pain levels were significantly higher than those reported to have been observed by their providers (P < 0.001). ConclusionPatients' and providers' responses suggested that the IUD insertion procedure under our current practice appeared acceptable to most patients. However, providers were not usually accurate in their observations and tended to underestimate the degree of pain experienced by their patients during IUD insertion procedures.

show abstract

Section: Differences In Results In Relation To Other Studiesmentioning

confidence: 97%

Patients’ experiences and providers’ observations on pain during intrauterine device insertion

Akintomide¹,

Brima

Sewell

et al. 2015

The European Journal of Contraception & Reproductive Health

View full text Add to dashboard Cite

show abstract

“…These devices are the most popular in developing countries. 6,34 Arancibia et al 1 reported that cuprous was undetectable in uterine fluid samples. They confirmed that in aqueous solutions, like uterine solution, the life of these ions is very short because they quickly react to become cupric.…”

Section: Discussionmentioning

confidence: 99%

“…The wire surface is similar to those of Copper T200 IUD (TCu 200, 200 mm 2 ) and Copper T220 IUD (220 mm 2 ) and half of the area of IUD T380 surface (380 mm 2 ). These devices are the most popular in developing countries. , Arancibia et al reported that cuprous was undetectable in uterine fluid samples. They confirmed that in aqueous solutions, like uterine solution, the life of these ions is very short because they quickly react to become cupric.…”

Section: Discussionmentioning

confidence: 99%

Decrease in Cytotoxicity of Copper-Based Intrauterine Devices (IUD) Pretreated with 6-Mercaptopurine and Pterin as Biocompatible Corrosion Inhibitors

Álvarez

Grillo

Schilardi

et al. 2013

ACS Appl. Mater. Interfaces

View full text Add to dashboard Cite

The copper intrauterine device (IUD) based its contraceptive action on the release of cupric ions from a copper wire. Immediately after the insertion, a burst release of copper ions occurs, which may be associated to a variety of side effects. 6-Mercaptopurine (6-MP) and pterin (PT) have been proposed as corrosion inhibitors to reduce this harmful release. Pretreatments with 1 × 10(-4) M 6-MP and 1 × 10(-4) M PT solutions with 1h and 3h immersion times were tested. Conventional electrochemical techniques, EDX and XPS analysis, and cytotoxicity assays with HeLa cell line were employed to investigate the corrosion behavior and biocompatibility of copper with and without treatments. Results showed that copper samples treated with PT and 6-MP solutions for 3 and 1 h, respectively, are more biocompatible than those without treatment. Besides, the treatment reduces the burst release effect of copper in simulated uterine solutions during the first week after the insertion. It was concluded that PT and 6-MP treatments are promising strategies able to reduce the side effects related to the "burst release" of copper-based IUD without altering the contraceptive action.

show abstract

“…Whether the current grouping of contraceptive methods by effectiveness based on U.S. data are valid in developing world settings is unclear. Estimates from prospective studies focusing on only one method are available for many methods (eg, implants, 11 injectables, 12 IUD, 13,14 and OCPs 15 ) from a limited number of developing countries. Generally, these studies show the same effectiveness groupings of contraceptive methods as when U.S. data are used.…”

mentioning

confidence: 99%

Pregnancy Risk Among Oral Contraceptive Pill, Injectable Contraceptive, and Condom Users in Uganda, Zimbabwe, and Thailand

Steiner¹,

Kwok²,

Dominik³

et al. 2007

Obstetrics &Amp; Gynecology

View full text Add to dashboard Cite

show abstract

Clinical performance of the TCu 380A and TCu 220C IUDs in four developing country family planning clinics

Cited by 15 publications

References 16 publications

Patients’ experiences and providers’ observations on pain during intrauterine device insertion

Patients’ experiences and providers’ observations on pain during intrauterine device insertion

Decrease in Cytotoxicity of Copper-Based Intrauterine Devices (IUD) Pretreated with 6-Mercaptopurine and Pterin as Biocompatible Corrosion Inhibitors

Pregnancy Risk Among Oral Contraceptive Pill, Injectable Contraceptive, and Condom Users in Uganda, Zimbabwe, and Thailand

Contact Info

Product

Resources

About